MedTrace Logo

The Role of Active Administration of Peristeen Bowel Evacuation for the Management of Urinary Tract Infection

NCT04815226 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-05-06

No results posted yet for this study

Summary

This study investigates whether active use of transanal irrigation (Peristeen®) effectively manages urinary tract infection among patients with the diagnosis of neurogenic bladder.

Conditions

  • Neurogenic Bladder
  • Neurogenic Bowel
  • Spina Bifida
  • Fecal Incontinence
  • Fecal Impaction
  • Urinary Incontinence

Interventions

DEVICE

Peristeen Transanal Irrigation

Using Peristeen Transanal Irrigation twice per week for 12 weeks

Sponsors & Collaborators

  • Coloplast A/S

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kwanjin Park, M.D. Ph.D · Seoul National University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-14
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04815226 on ClinicalTrials.gov